NeuroCreate Ltd

Meet NeuroCreate Ltd.

NeuroCreate builds creative technology workflow tools that not only assist creative productivity, but actively incorporate health and cognitive wellbeing design, by facilitating Flow mental states.

The Team

Shama Rahman

neuro create logo

About Us

Dr. Shama Rahman, an expert in AI, neuroscience, and creative industries, leads NeuroCreate by integrating neuroscientific principles with human-centered design. With 15 years of experience, she productized her PhD research on creative cognition, managing R&D, fundraising, and pilots. Zee West, a serial entrepreneur, excels in partnerships and strategy, while Ve Dewey, with 15 years at brands like Adobe, focuses on tech, design, and inclusive leadership, ensuring long-term impact.

Problem

From 2020 to 2050, the global population aged 60+ is expected to double to 2.1 billion, comprising 22% of the world's population. This surge presents significant challenges, particularly in extending healthspan and longevity. Workforce demographics are shifting, with over 50s contributing to 80% of employment growth over the past decade. By 2030, over 55s will make up 18% of the labor force, emphasizing the need to maintain cognitive performance. Chronic stress is linked to cognitive decline and accelerated aging, highlighting the importance of stress resilience interventions.

Solution

During Dr. Rahman's PhD research, she discovered a signature brain pattern linked to 'Flow' mental states. As Founder/CEO of NeuroCreate, she is developing the FlowCreate™ platform, which integrates AI, neuroscience, and design to help users achieve Flow in their workflows. Flow enhances cognitive flexibility, creativity, stress resilience, motivation, engagement, mood, and overall well-being. The platform uses cognitive training, creative techniques, and audio-visual cues to nudge users into Flow, promoting productivity and healthy aging. NeuroCreate envisions a future where well-being, creativity, and cognitive enhancement are just as important as productivity, with a focus on AI-human collaboration to support these goals.

One of the co-pilots aids innovation workflows for the creative industries. It is the first AI-augmented innovation platform leveraging the neuroscience of creativity to help individuals and teams collaborate on their next big breakthrough. 

Market

Our go-to-market strategy is to position ourselves as creative technology and innovation management with SOM being £4billion within this initial segment of the market (SAM £41bill).After this initial emphasis on directly augmenting creative processes through improved creative cognition, we can continue to build on our preliminary studies that already show improved cognitive flexibility, stress resilience & mood within our users. We can further validate this and refine our products accordingly across different age-groups for healthy ageing. This widens our target to a £92billion market beyond the ‘Enterprise Collaboration’ market to include the 'Wellbeing in the Workplace’ market. 

This article was published on